Skip to main content
. 2020 Oct 21;2020(10):CD013750. doi: 10.1002/14651858.CD013750

8.2. Analysis.

8.2

Comparison 8: Platinum vs non‐platinum regimens (sensitivity analysis 1: included in OS meta‐analysis vs. not included in OS meta‐analysis), Outcome 2: Objective tumour response rate (assessable participants)